ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,376 | +26.2% | 2,753 | +22.4% | 0.00% | – |
| Q2 2023 | $44,668 | +30.5% | 2,249 | +12.5% | 0.00% | – |
| Q1 2023 | $34,224 | -9.4% | 1,999 | +4.0% | 0.00% | – |
| Q4 2022 | $37,795 | +1159.8% | 1,923 | +861.5% | 0.00% | – |
| Q3 2022 | $3,000 | -25.0% | 200 | -18.4% | 0.00% | – |
| Q2 2022 | $4,000 | 0.0% | 245 | -14.6% | 0.00% | – |
| Q1 2022 | $4,000 | -33.3% | 287 | -7.1% | 0.00% | – |
| Q4 2021 | $6,000 | -25.0% | 309 | +12.0% | 0.00% | – |
| Q3 2021 | $8,000 | -33.3% | 276 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | -25.0% | 276 | -26.2% | 0.00% | – |
| Q1 2021 | $16,000 | +23.1% | 374 | +61.9% | 0.00% | – |
| Q4 2020 | $13,000 | +1200.0% | 231 | +645.2% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 31 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 31 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 31 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
| RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
| Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
| Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
| Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
| COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
| Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
| Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
| MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |